USD 87.46
(-0.78%)
Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
---|---|---|---|---|---|---|
Operating Cash Flow | 3.57 Billion | 2.8 Billion | 4.29 Billion | 2.78 Billion | 1.91 Billion | 2.23 Billion |
Net Income | 2.42 Billion | 2.64 Billion | 3.41 Billion | 1.57 Billion | 1.49 Billion | 1.54 Billion |
Depreciation & Amortization | 833.6 Million | 796.3 Million | 806 Million | 775.6 Million | 764.4 Million | 674.3 Million |
Deferred income taxes | -59.1 Million | 117.3 Million | -126.3 Million | -63.5 Million | -21 Million | -50.4 Million |
Stock-based compensation | 1.2 Million | 1.6 Million | 1.3 Million | 1.3 Million | 1.3 Million | 600 Thousand |
Change in working capital | 310 Million | -838.9 Million | 190.7 Million | 483.6 Million | -347 Million | 22.6 Million |
Other non-cash items | 1.73 Billion | 78.2 Million | 816.8 Million | 8.6 Million | 22.3 Million | 714.7 Million |
Investing Cash Flow | -1.39 Billion | -666.8 Million | -972.9 Million | -915.8 Million | -574 Million | -1.29 Billion |
Investments in PPE | -1 Billion | -948.5 Million | -892.3 Million | -592.2 Million | -707.5 Million | -1.12 Billion |
Acquisitions | - | - | 892.3 Million | 592.2 Million | 707.5 Million | - |
Investment purchases | -808.7 Million | -486.2 Million | -1.65 Billion | -450.3 Million | -284.4 Million | -310.6 Million |
Sales/Maturities of investments | 417.7 Million | 764.7 Million | 1.57 Billion | 120.2 Million | 133.1 Million | 147.3 Million |
Other Investing Activities | 1.2 Million | 3.2 Million | -896.8 Million | -585.7 Million | -422.7 Million | -11.5 Million |
Financing Cash Flow | -3.1 Billion | -3.01 Billion | -2.48 Billion | -1.56 Billion | -262.2 Million | -1.08 Billion |
Debt repayment | - | -300 Million | - | -400 Million | -977.5 Million | - |
Dividends payments | -3.09 Billion | -2.7 Billion | -2.47 Billion | -1.15 Billion | -1.23 Billion | -1.08 Billion |
Common Stock Repurchased | - | - | - | - | - | - |
Common Stock Issuance | - | - | - | - | - | - |
Other Financing Activities | -8.8 Million | -5.2 Million | -6.4 Million | -3.5 Million | 1.95 Billion | -1.1 Million |
Accounts receivables | 253 Million | -35.4 Million | -289.8 Million | -236 Million | -10.5 Million | 68.3 Million |
Accounts payables | 152.1 Million | -718 Million | 558.2 Million | 313.7 Million | -184.9 Million | 116.7 Million |
Inventory | -60.4 Million | -7.7 Million | 4.7 Million | 223.6 Million | -88.7 Million | -190.8 Million |
Other working capital | -34.7 Million | -77.8 Million | -82.4 Million | 182.3 Million | -62.9 Million | 28.4 Million |
Cash at beginning of period | 2.06 Billion | 3 Billion | 2.18 Billion | 1.92 Billion | 844.6 Million | 1 Billion |
Cash at end of period | 1.15 Billion | 2.06 Billion | 3 Billion | 2.18 Billion | 1.92 Billion | 844.6 Million |
Capital Expenditure | -1 Billion | -948.5 Million | -892.3 Million | -592.2 Million | -707.5 Million | -1.12 Billion |
Effect of forex changes on cash | 8.3 Million | -57 Million | -20.9 Million | -46 Million | 4.8 Million | -15.7 Million |
Net cash flow / Change in cash | -918.19 Million | -932.3 Million | 818.4 Million | 258.5 Million | 1.08 Billion | -160.2 Million |
Free Cash Flow | 2.56 Billion | 1.85 Billion | 3.4 Billion | 2.19 Billion | 1.2 Billion | 1.11 Billion |
Breakdown | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 |
---|---|---|---|---|---|---|
Operating Cash Flow | - | - | - | - | - | - |
Net Income | 899.8 Million | 950.2 Million | 736 Million | 445 Million | 2.42 Billion | 622 Million |
Depreciation & Amortization | 213.1 Million | 209.6 Million | 209 Million | 208.2 Million | 833.6 Million | 212.5 Million |
Deferred income taxes | -25.5 Million | 4.09 Million | 19.1 Million | -15.8 Million | -59.1 Million | -49.6 Million |
Stock-based compensation | -300 Thousand | 100 Thousand | 200 Thousand | 700 Thousand | 1.2 Million | 200 Thousand |
Change in working capital | 352.6 Million | -202.2 Million | -310.8 Million | -116.4 Million | 310 Million | 265 Million |
Other non-cash items | 2.7 Million | 910.3 Million | 433.6 Million | 436.4 Million | 1.73 Billion | -300 Thousand |
Investing Cash Flow | -236.1 Million | -331.7 Million | 56.2 Million | -607 Million | -1.39 Billion | -509 Million |
Investments in PPE | -246.4 Million | -331.8 Million | -213.8 Million | -255.4 Million | -1 Billion | -262.7 Million |
Acquisitions | - | - | - | - | - | 262.7 Million |
Investment purchases | 10.4 Million | - | 270.1 Million | -769.9 Million | -808.7 Million | -246.8 Million |
Sales/Maturities of investments | 10.3 Million | 100 Thousand | 270 Million | 417.7 Million | 417.7 Million | -246.8 Million |
Other Investing Activities | -246.4 Million | 100 Thousand | 270 Million | 600 Thousand | 1.2 Million | -15.4 Million |
Financing Cash Flow | -471.1 Million | - | -620.1 Million | -775.5 Million | -3.1 Billion | -775.1 Million |
Debt repayment | - | - | - | - | - | - |
Dividends payments | -468.8 Million | - | -618.5 Million | -773.1 Million | -3.09 Billion | -773.1 Million |
Common Stock Repurchased | - | - | - | - | - | - |
Common Stock Issuance | - | - | - | - | - | - |
Other Financing Activities | -2.3 Million | - | -1.6 Million | -2.4 Million | -8.8 Million | -2 Million |
Accounts receivables | 92.1 Million | -328.4 Million | -152.8 Million | -10.1 Million | 253 Million | -63.1 Million |
Accounts payables | 22.5 Million | -145.6 Million | 151.8 Million | 98.3 Million | 152.1 Million | 226.5 Million |
Inventory | 29.39 Million | -16.7 Million | -8.19 Million | -73.6 Million | -60.4 Million | -2.4 Million |
Other working capital | 352.6 Million | 288.5 Million | -301.6 Million | -131 Million | -34.7 Million | 104 Million |
Cash at beginning of period | 1.87 Billion | 1.25 Billion | 1.15 Billion | 1.96 Billion | 2.06 Billion | 2.19 Billion |
Cash at end of period | 779.4 Million | 1.87 Billion | 1.25 Billion | 1.15 Billion | 1.15 Billion | -231.9 Million |
Capital Expenditure | -246.4 Million | -331.8 Million | -213.8 Million | -255.4 Million | -1 Billion | -262.7 Million |
Effect of forex changes on cash | 47.1 Million | -7.3 Million | 4.9 Million | 25.9 Million | 8.3 Million | 2.4 Million |
Net cash flow / Change in cash | -1.09 Billion | 623.1 Million | 100.7 Million | -815.6 Million | -918.19 Million | -2.43 Billion |
Free Cash Flow | 1.19 Billion | 630.3 Million | 445.9 Million | 285.6 Million | 2.56 Billion | 787.1 Million |
HSIC
TSRUF
CRESW
MME
WOCKPHARMA
603390